Last10K.com

Monterey Innovation Acquisition Corp (MTRY) SEC Filing 8-K Material Event for the period ending Monday, October 9, 2023

Monterey Bio Acquisition Corp

HISTORY TOOLS
CIK: 1860663 Ticker: MTRY

View differences made from one to another to evaluate Monterey Bio Acquisition Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Monterey Bio Acquisition Corp.

Continue

Assess how Monterey Bio Acquisition Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Monterey Bio Acquisition Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover
Ticker: MTRY
CIK: 1860663
Form Type: 8-K Corporate News
Accession Number: 0001104659-23-109099
Submitted to the SEC: Fri Oct 13 2023 4:05:45 PM EST
Accepted by the SEC: Fri Oct 13 2023
Period: Monday, October 9, 2023
Industry: Blank Checks
Events:
  1. Listing Status

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/mtry/0001104659-23-109099.htm